Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes.

MLA

Ciulla, Thomas, et al. “Visual Acuity Outcomes and Anti-VEGF Therapy Intensity in Macular Oedema Due to Retinal Vein Occlusion: A Real-World Analysis of 15 613 Patient Eyes.” British Journal of Ophthalmology, vol. 105, no. 12, Dec. 2021, pp. 1696–704. EBSCOhost, https://doi.org/10.1136/bjophthalmol-2020-317337.

APA

Ciulla, T., Pollack, J. S., & Williams, D. F. (2021). Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes. British Journal of Ophthalmology, 105(12), 1696–1704. https://doi.org/10.1136/bjophthalmol-2020-317337

Chicago

Ciulla, Thomas, John S. Pollack, and David F. Williams. 2021. “Visual Acuity Outcomes and Anti-VEGF Therapy Intensity in Macular Oedema Due to Retinal Vein Occlusion: A Real-World Analysis of 15 613 Patient Eyes.” British Journal of Ophthalmology 105 (12): 1696–1704. doi:10.1136/bjophthalmol-2020-317337.